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SUMMARY
Weresolvedtoprescribefolicacidsupplementsforall women whoattendedthis
practice during the first twelve weeks of pregnancy. Six months after this
decision a prescription was recorded in only 13% ofcases: this compared with
18% duringthe twomonths immediately followingthedecision. It wasresolved
to improve this performance and observations six months later revealed a
prescription recorded in 63% ofcases. Subsequently a new form for recording
anantenatalconsultation wasdevisedandsixmonthsafteritsimplementation,
100% recordingoffolateprescription forappropriatecases wasobserved. It was
concluded that these simple audit exercises prompted changes in practice
which helped to improve standards ofpatient care.
INTRODUCTION
In 1992 the Department of Health and Social Services sent a circular I to
general practitioners advising that women should take folic acid supplements
priorto conception and during the first twelve weeks ofpregnancy with the aim
ofreducing the incidence ofneural tube defects. Many ofour patients had diets
which were low in folate, therefore we decided that we should prescribe folate
supplements forthosewhopresented to us atlessthantwelveweeks' gestation.
Werecognisedthatthose whodidnotpresentbeforethe sixth weekofgestation
would notbe protectedfrom neural tube defects 2 in theircurrent pregnancy but
thatthe advice given with thesupplements should have some benefit in relation
to future pregnancies. Our aim was that all patients presenting before the
twelfth week of their pregnancy should have a record in their notes of having
been prescribed folic acid.
METHOD
The study was based within one group general practice in an area of Belfast of
low socio-economic class. Patients who were pregnant, less than twelve weeks
gestation and consulted their general practitioner during May or June 1993
were identified from practice records. The medical notes of all these patients
were examined manually and a data sheet was completed for each patient,
recording details of their age, gestation at presentation, number of previous
pregnancies and personal or family history of neural tube defects, in addition
to information regarding folate prescription.
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In order to set a background against which to view these findings, we carried
out the same exercise for patients who presented during January or February
1993, immediately following the decision regarding our practice policy for
folateprescription. Thesameexercisewasrepeatedagainforpatientspresenting
in January or February 1994, six months after the original observations were
made and partners had resolvedtoimprovetheirperformance. Followingthese
observations one partner designed a new form for recording an antenatal
consultation. Thiswas incorporated into routine practice andthe auditexercise
was again repeated for patients presenting in May or June 1994.
RESULTS:
Atotal of96 patients' records were examined. Their ages ranged from 16 to 42
years, with almost 70% being aged between 20 and 30 years. Approximately
20%ofpatients presentingforcarewereprimigravidae. Themajorityofpatients
(60%) had one, two or three previous pregnancies, the highest number noted
being nine. One patient had a previous baby with a neural tube defect and six
others had a family history of neural tube defect recorded. Of all the patients
presenting atlessthantwelveweeks' gestation, only 25%presentedbeforetheir
seventhweek: most (52%) presented atseven oreightweeksandtheremainder
later than this.
TABLE
Frequency ofrecordoffolateprescriptionsforpatientspresentingatless than 12
weeks' gestation for each observation period.
Number ofpatients (%)
Observation Folate Folate
Period Prescription Prescription Total
Recorded Not recorded
Jan/Feb 1993 5 (18.5) 22 (81.5) 27
May/June 1993 3 (13) 20 (87) 23
Jan/Feb 1994 14 (63.6) 8 (36.4) 22
May/June 1994 24 (100) 0 (0) 24
The table shows thefrequencies ofa record offolic acidhaving been prescribed
for patients during the four periods of observation, displayed in chronological
order. The initial audit, done for patients presenting in May and June of 1993,
showed a positive record in only 13%ofcases. In comparison, a figure of 18.5%
was noted immediately following the practice's decision to prescribe it; 63.6%
after resolution to improve performance and 100% after implementation of a
new form for an antenatal consultation.
DISCUSSION
Although neuraltubedefectisa problemwhichisofrelevancetothecommunity
within Northern Ireland and despite a DHSS recommendation in 1992 that
women should take folic acid supplements prior to conception and during the
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first twelve weeks of pregnancy as a preventive measure,' there is scant
evidenceofmasspubliceducationonthis. Thefailureofhealthcareprofessionals
in providing this message was reflected in a recent report ofwomen attending
antenatal clinics in London: only 5% reported a preconceptual increase in folic
acidconsumption, 26%did increasetheirconsumption whenthey realisedthey
were pregnant but 67% were unaware of its value.3
The community within which the currently reported study took place tends not
to eat a diet rich in folate: fresh vegetables, fruit and fortified breakfast cereals,
which are good sources of folate, are not commonly consumed. Many
pregnancies are not planned and, amongst those which are, we as general
practitioners are not aware of many in which folate supplements have been
taken prior to conception. Hence, we felt it was worthwhile to prescribe folate
supplements forwomen presenting at less than 12 weeks gestation and to give
them advice relating to future pregnancies. Previous studies have shown that
patientsgenerallydowelcomeadvicefromtheirgeneral practitionersregarding
lifestyle habits, including diet.4
The results ofour study show, however, that it is important not merely to make
a decision, but also to observe its outcome. The findings ofthe initial period of
observation, only 13% of appropriate cases being recorded as having been
prescribed folic acid, were a matter of concern to the general practitioners. All
felt that they had been more diligent in their adherence to the practice decision
thantheobservations indicated. Consequentlytherewasanavowedcommitment
to more diligent recording of prescribing but repeat observations six months
later, despite showing considerable improvement (63%), revealed a shortfall in
the desired standards of care.
An advised method of improving quality of care is to solve problems and
implement change.5 The solution devised for the current problem was the
design of a new form on which to record details of an antenatal consultation,
with specific spaces allocated to documenting family and personal history of
spina bifida, provision of folate supplements and dietary advice. The result of
the reaudit of the practice's performance with regard to prescribing folic acid
forwomen presenting atlessthantwelveweeksgestationwasbothencouraging
and rewarding: records showed 100% achievement of the target.
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